Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
  Home Print this page Email this page Small font sizeDefault font sizeIncrease font size Users Online: 308  

    Article Cited by others


The World Association of Radiopharmaceutical and Molecular Therapy position statement on the initial radioiodine therapy for differentiated thyroid carcinoma

Dizdarevic S, Tulchinsky M, McCready V R, Mihailovic J, Vinjamuri S, Buscombe J R, Lee S T, Frangos S, Sathekge M, Siraj Q, Choudhury P, Bom H, Franceschi M, Ugrinska A, Paez D, Hussain R, Mailman J, Luster M, Virgolini I, On behalf of the WARMTH Thyroid Group

Year : 2019| Volume: 18| Issue : 2 | Page no: 123-126

   This article has been cited by
1 Contemporary considerations in adjuvant radioiodine treatment of adults with differentiated thyroid cancer
Malik E. Juweid,Mark Tulchinsky,Ayman Mismar,Munther Momani,Ayman A. Zayed,Hussam Al Hawari,Nader Albsoul,Felix M. Mottaghy
International Journal of Cancer. 2020;
[Pubmed]  [Google Scholar] [DOI]
2 Radiotheragnostics Paradigm for Radioactive Iodine (Iodide) Management of Differentiated Thyroid Cancer
Einat Slonimsky,Mark Tulchinsky
Current Pharmaceutical Design. 2020; 26(31): 3812
[Pubmed]  [Google Scholar] [DOI]


Read this article